Contact Us Support

Kastango Consulting Group – Meet the Team

Eric S. Kastango, MBA, BS Pharm, FASHP

Eric S. Kastango, MBA, BS Pharm, FASHP, Vice President and Managing Partner of the Kastango Consulting Group, LLC® (KCG), a TRC Healthcare-affiliated company.

Mr. Kastango received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Master of Business Administration degree from the University of Phoenix. He completed 65 hours of training in nuclear pharmacy at Purdue University and 80 hours of educational training for the Six Sigma Green Belt certification that he started with BD Medical Systems. He is currently attending Johns Hopkins Bloomberg School of Public Health, working towards a master’s in public health.

Since 1980, he has practiced pharmacy in a number of practice settings, including hospitals, community, and home care in several different roles, including the Corporate Vice President of Pharmacy Services for Coram Healthcare Corporation. He has also managed an FDA-registered cGMP manufacturing operation for Baxter Healthcare Corporation.

Eric received a coveted ISMP Cheers Award in 2015 for his work related to sterile compounding safety. He was one of four recipients of the 2013 Outstanding Service Award from the Massachusetts Society of Health-System Pharmacists and the 2014 recipient of the NABP Henry Cade Memorial Award, which recognized his efforts and assistance to the states and NABP to address the NECC compounding tragedy that occurred in 2012.

He is an active member and Fellow of the American Society of Healthcare Pharmacists and served for eight years on the USP Sterile Compounding Committee from 2005 until April 2013. In May 2013, USP recognized Eric and the members of the Compounding Expert Committee with an Award for Outstanding Contribution to the USP standards-setting process. He has also served on the USP Hazardous Drug Expert Panel from 2011 to 2016. Eric continues to serve as a sterile compounding, outsourcing, and patient-safety subject matter expert for the American Society of Health-System Pharmacists, State Boards of Pharmacy and was one of the key US Department of Justice expert witnesses during the New England Compounding Center trials from 2017 to 2019.

Joseph W. Coyne, RPh, BSCSP

Joseph W. Coyne, RPh, currently serves as the Director of Field Operations for KCG where he has been since 2017.

Before joining forces with the KCG team, Joe served as President and CEO of Coyne Consulting. Before that, he served as the Enterprise Vice President of Pharmacy Services for Cancer Treatment Centers of America (CTCA).

Joe has practiced pharmacy in many different capacities and settings, including hospitals, community-based retail, long-term care, hospice, and home care.

Joe is a trusted speaker who has presented nationally and internationally on various pharmacy-practice topics such as pharmacy compounding, hazardous drug handling, and quality standards. He has presented at the local, state, and national levels to state pharmacy and hospital associations, national society meetings, and Fortune 500 companies. He is also currently serving as a faculty member at the CriticalPoint Center for Training and Research® (CCTR), presenting on the topics of hazardous drug handling and aseptic preparation.

Joe continues to contribute to numerous industry publications, including ASHP’s Compounding Sterile Preparations, 4th Edition, for which he co-authored the Hazardous Drug Handling Chapter, and is co-authoring the ASHP Hazardous Drug Handling Technician Bulletin revision. He is also an active member of the American Society of Health-System Pharmacists (ASHP). He has served on the board of directors for several organizations, including Chicago-based health system and an international veterinary compounding pharmacy.
Joe received his Bachelor of Science degree in Pharmacy from the Philadelphia College of Pharmacy and Science where he served as Clinical Preceptor and an Adjunct Senior Clinical Professor of the Department of Pharmacy Practice.

Joe received his Compounded Sterile Preparations Certification from the Board of Pharmacy Specialties in the fall of 2019 as a member of its inaugural class.

Mary Nazzal, PharmD, BSCSP

Mary Nazzal, a PharmD, Registered Pharmacist, is the Associate Director of Field Operations for KCG.

She received her PharmD degree from Butler University of Indianapolis and has completed the Nuclear Pharmacy Certificate Program at Purdue University. Mary received her Compounded Sterile Preparations Certification from the Board of Pharmacy Specialties in the fall of 2019 as a member of its inaugural class.

She has over 14 years of progressive and diverse hospital pharmacist experience, including administrative, inpatient pharmacy, de-centralized pharmacy, and operating room with a focus in sterile compounding. Before joining KCG in 2017, Mary established and led sterile compounding services, including pharmacy-related policy/procedure/SOP development, technology setup and implementation, training development, and execution for Cleveland Clinic, Abu Dhabi in the United Arab Emirates. She performs gap analysis, facility design development, and review of construction documents for clients to ensure regulatory compliance as well as provide best practice recommendations regarding sterile compounding. She is also a member of the American Society of Health-System Pharmacists (ASHP) and Indiana Pharmacists Association.




Mark Bodnar, RPh

Mark Bodnar, BS Pharm, Registered Pharmacist, Rutgers University alumni is Director of Special Projects for KCG, with over 30 years’ experience in sterile compounding: hospital, infusion therapy/home, and LTC as well as FDA-regulated outsourcing facilities.

Mark’s focus through the years was the introduction and installation of GCP/GMP culture through quality systems management of SOP development, documentation, training, and CAPA. Mark performs construction document reviews to ensure regulatory compliance and recommends best practices for sterile compounding. He is also a peer reviewer for gap analysis, facility design development, and other related documents. Mark is a Rutgers University preceptor for IPPE and APPE pharmacy students during their rotation cycles. He also is involved with various medical device studies related to sterile compounding.

Kimberly Coughlin, B.S., RCP-SCF, NSF-49

Kimberly currently serves as the Director of Microbiology for KCG, joining in early 2019.

In her role, she provides consultation on environmental monitoring, remediation, and facility design performance. Kimberly is also responsible for reviewing regulatory compliance and performing onsite gap analysis at client facilities and audits of client vendors.

Kimberly has over 20 years of experience in microbiology laboratory testing, environmental monitoring, field testing, and certification of engineering controls in the pharmaceutical, medical device, research, and sterile compounding industries. During Kimberly’s industry tenure, she has worked with clients to develop meaningful environmental monitoring programs and successful remediation plans and has consulted on remedial efforts for engineering control performance issues.

Since 2015, Kimberly has served as a Director on the Controlled Environment Testing Association (CETA) Board of Directors. She is the 2019–2021 President-elect for CETA and Program Chair for the 2020 and 2021 annual meetings. Kimberly also serves as a subject matter expert (SME) for the CETA National Board of Testing’s (CNBT) Registered Certification Professional — Sterile Compounding Facilities (RCP-SCF) accreditation program. She served as the past Chair/Board Liaison of the CBNT Executive Committee and continues to serve as a committee member. She held a lead role in the writing of ISPE’s Good Practice Guide: HVAC and Process Equipment Air Filters. Kimberly received her Bachelor of Science degree in Environmental Science from Westfield State College. She received NSF Accreditation for the Field Certification of Class II Biosafety Cabinets and CETA accreditation as a Registered Certification Professional — Sterile Compounding Facilities.




Adam West, RCP-SCF, NSF-49

Adam West is the Environmental Monitoring and Training Specialist at CriticalPoint, LLC, a health-care training and development company.

In his current role, he is responsible for the development of live training curriculum and eLearning modules related to field certification and engineering control. He also works with KCG, providing consulting for environmental monitoring investigations and remediation, facility design, and certification of primary and secondary engineering controls for sterile compounding facilities.

Adam has over ten years of experience in the certification industry providing Field Certification Services for 503A and 503B sterile compounding facilities and pharmaceutical and medical device manufacturers. In addition to certification, he has extensive knowledge in viable environmental monitoring, including sampling plan development and remediation, and has provided consultation services for USP Chapter 797 and 800 facility design compliance. Adam holds the Registered Certification Professional – Sterile Compounding Facilities (RCP-SCF) certification and NSF-49 accreditation.

Melanie Dorey, RPhT, QP503A

Melanie Dorey, RPhT, is licensed in Canada as a Pharmacy Technician. She graduated from La Cite Collegiale in 2006 from a two-year pharmacy technician program that is specialized in sterile compounding.

She has been working as a technician at a pediatric hospital since 2006. Melanie also has served as an aseptic teacher (practical and theory) at an accredited pharmacy technician college in Ottawa since 2010. Melanie has been working with CriticalPoint since 2015. She is currently the lead Aseptic Instructor at CriticalPoint and runs a one-and-a-half-day class that includes lectures and hands-on learning and competencies in aseptic technique. Melanie is QP503A certified and serves as a subject matter expert for CriticalPoint for other areas such as nonsterile compounding development of standard operating procedures and eLearning, pharmacy math, hazardous compounding, video shoots, and editing as well as eCurriculum development. She also works with CriticalPoint’s sister company, KCG, as an aseptic consultant and offsite speaker. She travels to different sites to offer hands-on training and lectures on many different subjects, including cleaning, disinfecting, aseptic technique, hand hygiene and garbing, environmental monitoring, and compounder conduct. Melanie shares knowledge and theories to help make improvements in current work practices. She also assists facilities with developing and completing evaluations/competencies. Melanie has performed a variety of roles at the pediatric hospital. These roles include tech check tech, IV room lead, critical care technician, writing and reviewing standard operating procedures, medication reconciliation, pharmacy buyer, billing, research/study technician as well as performing as a preceptor to new employees. She has voluntarily joined NAPRA on a Review Committee for Compounding Competencies. Melanie has a passion for sharing knowledge and loves teaching the “why” behind the “how.”

Martha (Marty) Polovich, Ph.D., RN

Marty earned a Diploma in Nursing from Mount Sinai Hospital School of Nursing in Chicago; a Bachelor’s and Master’s degree in Nursing from Louisiana State University in New Orleans; and a Ph.D. in Nursing from Georgia State University in Atlanta.

Dr. Polovich is an RN with over 40 years of clinical practice. Currently, she teaches part-time at Byrdine F. Lewis College of Nursing and Health Professions at Georgia State University. Her research interest is the prevention of exposure to hazardous drugs. Marty has been an active member of the Oncology Nursing Society where she has served as both a Clinical Nurse Specialist and a liaison to the National Institute for Occupational Safety and Health’s Hazardous Drug Safe Handling Working Group.
Dr. Polovich was also a member of the USP expert panel for USP Chapter 800 Hazardous Drugs – Handling in Healthcare Settings. Marty continues to be a trusted speaker both nationally and internationally on hazardous drug safe handling.